Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 15;13(11):e0207259.
doi: 10.1371/journal.pone.0207259. eCollection 2018.

Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women

Affiliations

Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women

K B Beck et al. PLoS One. .

Abstract

Background: Smallpox vaccinations were stopped globally in 1980. Recent studies have shown that in women, being smallpox vaccinated was associated with a reduced risk of HIV infection compared with not being smallpox vaccinated. At the initial infection, HIV-1 most often uses CCR5 as a co-receptor to infect the T-lymphocytes. We therefore investigated whether smallpox vaccination is associated with a down-regulation of CCR5 on the surface of peripheral T-lymphocytes in healthy women in Guinea-Bissau.

Methods: We included HIV seronegative women from Bissau, Guinea-Bissau, born before 1974, with and without a smallpox vaccination scar. Blood samples were stabilised in a TransFix buffer solution and stained for flow cytometry according to a T-cell maturation profile.

Results: Ninety-seven women were included in the study; 52 with a smallpox vaccination scar and 45 without a scar. No association between smallpox vaccination scar and CCR5 expression was found in any T-lymphocyte subtype.

Conclusion: Among HIV seronegative women, being smallpox vaccinated more than 40 years ago was not associated with a down-regulation of CCR5 receptors on the surface of peripheral T-lymphocytes.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flowchart of participants included in the study.
*In parenthesis number of women with and without scar from smallpox vaccination in the given group. No SV = no smallpox vaccination, SV = smallpox vaccination.
Fig 2
Fig 2. Plots of gating of CD4 and CD8 T-lymphocytes from flow cytometry.
A) Singlets, B) lymphocytes, C) T-lymphocytes, D) CD4 and CD8 T-lymphocytes, E) Effector Memory 1 CD4, F) Central Memory and Naive CD4, G) Effector Memory 2 and Effector Memory 3, H) 4th Antigen Experienced, I) Naive CD8 and 1st Antigen Experienced, J) 2nd and 3rd Antigen Experienced.
Fig 3
Fig 3. CCR5 positive cell fraction on CD4 subsets in women with and without a smallpox vaccination scar.
Grey colour is smallpox vaccination and black colour is no smallpox vaccination. CCR5 positive cell fraction of CD4 subsets in the two groups. Mean with SD. Central Memory (CM), Effector Memory 1 (EM1), Effector Memory 2 (EM2), Effector Memory 3 (EM3).
Fig 4
Fig 4. CCR5 positive cell fraction on CD8 subsets in smallpox vaccination group and no-smallpox vaccination group.
Grey colour is smallpox vaccination and black colour is no smallpox vaccination. CCR5 positive cell fraction of CD8 subsets in the two groups. Mean with SD. 1. Antigen Experienced (1AE), 2. Antigen Experienced (2AE), 3. Antigen Experienced (3AE), 4. Antigen Experienced (4AE).
Fig 5
Fig 5. Plots of CD4 T-lymphocytes from flow cytometry.
A) CD4 T-lymphocytes gated by CD45RA and CCR5, B) CD4 T-lymphocytes gated by FSC-H and CCR5, C) Naïve CD4 T-lymphocytes gated by FSC-H and CCR5, D) Effector Memory 2 CD4 T-lymphocytes gated by FSC-H and CCR5.
Fig 6
Fig 6. Plots of CD8 T-lymphocytes from flow cytometry.
A) CD8 T-lymphocytes gated by CD45RA and CCR5, B) CD8 T-lymphocytes gated by FSC-H and CCR5, C) Naïve CD8 T-lymphocytes gated by FSC-H and CCR5, D)2. Antigen Experienced CD8 T-lymphocytes gated by FSC-H and CCR5.

Similar articles

Cited by

References

    1. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature medicine. 1996;2(11):1240–3. . - PubMed
    1. Symons J, Vandekerckhove L, Hutter G, Wensing AM, van Ham PM, Deeks SG, et al. Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014;59(4):596–600. 10.1093/cid/ciu284 . - DOI - PMC - PubMed
    1. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. The New England journal of medicine. 2009;360(7):692–8. 10.1056/NEJMoa0802905 . - DOI - PubMed
    1. Deria A, Jezek Z, Markvart K, Carrasco P, Weisfeld J. The world's last endemic case of smallpox: surveillance and containment measures. Bull World Health Organ. 1980;58(2):279–83. ; PubMed Central PMCID: PMCPMC2395794. - PMC - PubMed
    1. Ennis FA, Cruz J, Demkowicz WE Jr., Rothman AL, McClain DJ. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis. 2002;185(11):1657–9. 10.1086/340517 . - DOI - PubMed

Publication types

Substances